Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist
US9493524B2 · kind B2 · utility
2Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 7, 2014 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Jan 7, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using an ETB receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ETB receptor agonist is used alone or in combination with a second agent useful in the treatment of stroke or other cerebrovascular accident.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.